IL-9 identified as contributor to viral spread and airway inflammation in COVID-19

FHS
July 13, 2023
10:46 am

Researchers used a K18-hACE2 transgenic (ACE2.Tg) mouse model to demonstrate that interleukin-9 (IL-9).

CC-95775 by Bristol-Myers Squibb for Solid Tumor: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

July 8, 2023

Hospital-acquired pressure ulcers may hinder neurological recovery in spinal cord injury patients

Research led by The Ohio State University Wexner Medical Center and College of Medicine along with scientists at the Charité – Universitätsmedizin Berlin in Berlin,

December 9, 2024

Organigram Q1 Revenue Declines

Organigram Reports First Quarter Fiscal 2024 Results Achieved positive cash flow from operations, solidified #2 market position in Canada among licensed producers, significantly improved margins

February 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.